Product Information
CARDIZEM LA 240 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $4.3424 per EA under NDC 00187204730. Its NADAC has been published 200 times since May 14, 2014.
The High Outlier badge above means this manufacturer's average price in the Diltiazem Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
240 mg/1
Manufacturer
Bausch Health US LLCNDC
00187204730
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
3/19/2025
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021392On Market Since
12/25/2010
Pharmacological Classes
Price Statistics
The NADAC for CARDIZEM LA 240 MG TABLET has been published 200 times since May 14, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3424 per EA |
|---|---|
| All-time high | $4.5551 (Dec 16, 2015) |
| All-time low | $4.3078 (Apr 17, 2024) |
| 52-week high | $4.3424 |
| 52-week low | $4.3424 |
| Median price | $4.3430 |
| Average price | $4.3816 |
| Largest weekly change | +4.3% (Oct 21, 2015) |
| Weeks tracked | 200 |
| Tracking since | May 14, 2014 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARDIZEM LA 240 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARDIZEM LA 240 MG TABLET, manufactured by Bausch Health US LLC, is $4.3424 per EA (NDC 00187204730), effective Oct 1, 2025.
How has the price of CARDIZEM LA 240 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARDIZEM LA 240 MG TABLET has held within roughly two percent of its current level. It has been tracked across 200 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for CARDIZEM LA 240 MG TABLET?
Since May 14, 2014, the NADAC for CARDIZEM LA 240 MG TABLET has ranged from a low of $4.3078 (Apr 17, 2024) to a high of $4.5551 (Dec 16, 2015), with a median of $4.3430 per EA.
Are there cheaper alternatives to CARDIZEM LA 240 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DILTIAZEM 24HR ER 240 MG CAP, is $0.1482 per EA — about 97% below CARDIZEM LA 240 MG TABLET.
Who manufactures CARDIZEM LA 240 MG TABLET?
CARDIZEM LA 240 MG TABLET (NDC 00187204730) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification